84 related articles for article (PubMed ID: 26137223)
1. Analysis of alternatives for insulinizing patients to achieve glycemic control and avoid accompanying risks of hypoglycemia.
Gao J; Xiong Q; Miao J; Zhang Y; Xia L; Lu M; Zhang B; Chen Y; Zhang A; Yu C; Wang LZ
Biomed Rep; 2015 May; 3(3):284-288. PubMed ID: 26137223
[TBL] [Abstract][Full Text] [Related]
2. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
Ilag LL; Kerr L; Malone JK; Tan MH
Clin Ther; 2007; 29 Spec No():1254-70. PubMed ID: 18046926
[TBL] [Abstract][Full Text] [Related]
3. EADSG Guidelines: Insulin Therapy in Diabetes.
Silver B; Ramaiya K; Andrew SB; Fredrick O; Bajaj S; Kalra S; Charlotte BM; Claudine K; Makhoba A
Diabetes Ther; 2018 Apr; 9(2):449-492. PubMed ID: 29508275
[TBL] [Abstract][Full Text] [Related]
4. Addressing hyperglycemia from hospital admission to discharge.
Moghissi ES
Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
[TBL] [Abstract][Full Text] [Related]
5. Premixed Insulin Analogue Compared with Basal-Plus Regimen for Inpatient Glycemic Control.
Gracia-Ramos AE; Cruz-Domínguez MD; Madrigal-Santillán EO; Morales-González JA; Madrigal-Bujaidar E; Aguilar-Faisal JL
Diabetes Technol Ther; 2016 Nov; 18(11):705-712. PubMed ID: 27860499
[TBL] [Abstract][Full Text] [Related]
6. Intensive insulin therapy in hospitalized patients: a systematic review.
Kansagara D; Fu R; Freeman M; Wolf F; Helfand M
Ann Intern Med; 2011 Feb; 154(4):268-82. PubMed ID: 21320942
[TBL] [Abstract][Full Text] [Related]
7. The intriguing effects of time to glycemic goal in newly diagnosed type 2 diabetes after short-term intensive insulin therapy.
Cheng L; Xu M; Lin X; Tang J; Qi Y; Wan Y; Pan X; Chen X; Ren M; Yan L
Endocr J; 2016 Aug; 63(8):739-46. PubMed ID: 27334121
[TBL] [Abstract][Full Text] [Related]
8. Association of diabetic ketoacidosis, severe hypoglycemia and glycemic control among children and young adults with type 1 diabetes mellitus treated with premixed versus basal-bolus insulin therapy.
Chou WY; Li YR; Chan WK; Chen ST
Biomed J; 2018 Dec; 41(6):348-355. PubMed ID: 30709576
[TBL] [Abstract][Full Text] [Related]
9. Relation Between Hypoglycemia and Glycemic Variability in Type 2 Diabetes Patients with Insulin Therapy: A Study Based on Continuous Glucose Monitoring.
Uemura F; Okada Y; Torimoto K; Tanaka Y
Diabetes Technol Ther; 2018 Feb; 20(2):140-146. PubMed ID: 29293363
[TBL] [Abstract][Full Text] [Related]
10. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians.
Qaseem A; Humphrey LL; Chou R; Snow V; Shekelle P;
Ann Intern Med; 2011 Feb; 154(4):260-7. PubMed ID: 21320941
[TBL] [Abstract][Full Text] [Related]
11. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.
Vinik A
Clin Ther; 2007; 29 Spec No():1236-53. PubMed ID: 18046925
[TBL] [Abstract][Full Text] [Related]
12. Retrospective review of postoperative glycemic control in patients after distal pancreatectomy.
Liu A; Carmichael KA; Schallom ME; Klinkenberg WD
Int J Surg; 2017 May; 41():86-90. PubMed ID: 28347869
[TBL] [Abstract][Full Text] [Related]
13. Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes.
Lipska KJ; Parker MM; Moffet HH; Huang ES; Karter AJ
JAMA; 2018 Jul; 320(1):53-62. PubMed ID: 29936529
[TBL] [Abstract][Full Text] [Related]
14. Glycemic control in medical inpatients with type 2 diabetes mellitus receiving sliding scale insulin regimens versus routine diabetes medications: a multicenter randomized controlled trial.
Dickerson LM; Ye X; Sack JL; Hueston WJ
Ann Fam Med; 2003; 1(1):29-35. PubMed ID: 15043177
[TBL] [Abstract][Full Text] [Related]
15. Type 1 diabetes mellitus: effective insulin strategies with less hypoglycemia.
Bolli GB
Postgrad Med; 2004 Nov; 116(5 Suppl Exploring):13-20. PubMed ID: 19667675
[TBL] [Abstract][Full Text] [Related]
16. Insulin therapy in type 2 diabetes.
Mudaliar S; Edelman SV
Endocrinol Metab Clin North Am; 2001 Dec; 30(4):935-82. PubMed ID: 11727406
[TBL] [Abstract][Full Text] [Related]
17. Retrospective Evaluation of Glycemic Control With Basal-Bolus or Neutral Protamine Hagedorn Insulin Regimens in Patients Receiving Continuous Enteral Nutrition Therapy in Medicine Wards.
Hijaze D; Szalat A
Nutr Clin Pract; 2017 Aug; 32(4):557-562. PubMed ID: 28760108
[TBL] [Abstract][Full Text] [Related]
18. Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis.
Marik PE; Preiser JC
Chest; 2010 Mar; 137(3):544-51. PubMed ID: 20018803
[TBL] [Abstract][Full Text] [Related]
19. Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues.
Rolla AR; Rakel RE
Clin Ther; 2005 Aug; 27(8):1113-25. PubMed ID: 16199240
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Effectiveness of Continuous Subcutaneous Insulin Infusion in the Prevention of Hypoglycemia in Adults with Type 1 Diabetes.
Summers JC; Briganti EM; Fitzgerald ZA; Lambers LNJ; Cohen ND
Diabetes Technol Ther; 2019 Aug; 21(8):423-429. PubMed ID: 31180239
[No Abstract] [Full Text] [Related]
[Next] [New Search]
